Establishing network for future industries with Hypertrust Patient Data Care
Arvato and Hypertrust Patient Data Care (HPDC) join forces and launch the "Open X-CELLERATOR Community" with a joint event series.
The intention is to bring together all stakeholders who play a crucial role in providing patients with advanced and personalized therapies.
The development of advanced therapies, such as Cell & Gene Therapies (also called Advanced Therapy Medicinal Products, ATMP), brings with it a complexity of patient-specific processes as well as numerous stakeholders, that requires new supply chain strategies. For this reason, Arvato and HPDC have worked closely together to create a solution for the integrated orchestration of processes.
ATMPs, which are individually tailored to each patient, offer advanced options for treating serious and rare diseases. They are based on human genes, tissues, or cells with the aim of replacing non-functioning or defective cells in the human body or initiating processes for regeneration.
Arvato and HPDC are convinced that these advanced and personalized therapies require strong collaboration and trusted partnerships from a wide range of stakeholders to provide patients with the best possible care.
The vision of the "Open X-CELLERATOR Community" is to create an industry solution that enables access to ATMPs for more people while bringing together the right stakeholders. To achieve the common goal, Arvato and HPDC want to bring together all involved stakeholders along the patient journey and raise awareness for an industry solution.
The first community event will take place on September 23 at 4 pm (CET). as a virtual event. Here, experts and industry insiders will discuss their views and visions with an exclusive audience. The event consists of short keynote speeches and offers the opportunity to interact with the speakers as well as the community.
Speakers will be:
- Prof. Lutz Uharek,
expert in Cell and Gene therapies, CEO, and founder of Xencura GmbH - Christian Wolf,
Executive Vice President Healthcare at Arvato Supply Chain Solutions - Andreas Göbel,
Managing Director at Hypertrust Patient Data Care - Tol Trimborn, PhD,
Managing Director of Cellpoint - Dr. Andrea Zobel,
Senior Director Personalized Supply Chain at World Courier
Further X-CELLERATOR community events are planned, which will take place regularly as live events. The hosts hope to expand their community and thus actively support the providing of advanced therapies to patients and the process behind them in the future.
Participation is free of charge. Interested parties can register here.
About Hypertrust Patient Data Care
Hypertrust Patient Data Care (HPDC) provides specialized solutions and consulting services to optimize the supply chain of Advanced & Personalized Therapies. Hypertrust X-Chain enables pharmaceutical and biotech companies to set-up, orchestrate, operate and scale-up a frictionless supply chain that ensures highest data security based on latest technology, decentralization and pharmaceutical standards. HPDC products and services support all product lifecycle stages from pre-clinical trials to commercialization. With HPDC’s broad supplier and service provider ecosystem, companies can accelerate the setup of their Advanced & Personalized Therapy supply chain processes. Hypertrust is a spin-off of CAMELOT Consulting Group.
More information: www.hypertrust-patient.com